Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/17/2012US20120122769 Antisense antibacterial compounds and methods
05/17/2012US20120122768 Alginate oligomers for use in overcoming multidrug resistance in bacteria
05/17/2012US20120122764 Substituted carbamoylcycloalkyl acetic acid derivatives as nep
05/17/2012US20120122760 Novel lipids for transfection of nucleic acids
05/17/2012US20120122696 Use of oil based suspension concentrates for reducing drift during spray application
05/17/2012US20120122691 Cellulosic biocomposites as molecular scaffolds for nano-architectures
05/17/2012US20120122681 Pyridine Derivatives Compounds for Controlling Invertebrate Pests
05/17/2012US20120122217 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS
05/17/2012US20120122204 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
05/17/2012US20120122111 Rna sequence-specific mediators of rna interference
05/17/2012US20120121772 Purifying crude pufa oils
05/17/2012US20120121741 Water soluble defructosylated pea extract, and use thereof as a prebiotic agent
05/17/2012US20120121737 Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent
05/17/2012US20120121730 Pharmaceutical and nutraceutical compositions for treating respiratory disease and associated phlegm
05/17/2012US20120121729 Antitussive compositions comprising memantine
05/17/2012US20120121727 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
05/17/2012US20120121724 Film comprising therapeutic agents
05/17/2012US20120121720 Modulation of Beta 2 Adrenergic Receptors by Inhibitors of EGLN3 or pVHL
05/17/2012US20120121717 DRUG-LOADED POLYSACCHARIDE-COATED GOLDMAG PARTICLES (DPGPs) AND ITS SYNTHESIS METHOD
05/17/2012US20120121716 Pharmaceutical composition of an anthracycline
05/17/2012US20120121711 Microsphere drug carrier, preparation method, composition and use thereof
05/17/2012US20120121708 Acetazolamide Microparticle And Its Preparation Method And Use
05/17/2012US20120121707 Tolbutamide Particle And Preparing Method Thereof And Method Of Reducing A Blood Glucose
05/17/2012US20120121706 PAR-1 Activation by Metalloproteinase-1 (MMP-1)
05/17/2012US20120121704 Aliphatic Amine Polymer Salts for Tableting
05/17/2012US20120121703 Tablet containing ferric citrate
05/17/2012US20120121702 Controlled Release Azithromycin Solid Dosage Forms
05/17/2012US20120121700 Pharmaceutical formulations comprising valganciclovir
05/17/2012US20120121699 Lycopene and resveratrol dietary supplement
05/17/2012US20120121698 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
05/17/2012US20120121697 Compositions and Methods for the Diagnosis and Treatment of Inflammatory Disorders and Fibrotic Disease
05/17/2012US20120121696 Terpene Glycosides and Their Combinations as Solubilizing Agents
05/17/2012US20120121695 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylethanolamine
05/17/2012US20120121693 Methods for generating new hair follicles, treating baldness, and hair removal
05/17/2012US20120121691 Method for Increasing the Production of a Specific ACYL-Chain Dihydroceramide(s) for Improving the Effectiveness of Cancer Treatments
05/17/2012US20120121689 Small interfering rna delivery
05/17/2012US20120121687 Wound healing material and method for fabricating the same
05/17/2012US20120121686 Biodegradable compositions having pressure sensitive adhesive properties
05/17/2012US20120121684 Coating Comprising A Poly(Ethylene Glycol)-Poly(Lactide-Glycolide-Caprolactone) Interpenetrating Network
05/17/2012US20120121682 cRGD PEPTIDE DERIVATIVE AND ITS MANUFACTURE, AND IMPLANT HAVING A COATING CONTAINING A cRGD PEPTIDE DERIVATIVE
05/17/2012US20120121679 Viricidal and microbicidal compositions and uses thereof
05/17/2012US20120121676 Method for manufacturing capsules, resulting capsules, and use of said capsules
05/17/2012US20120121670 Polyarginine nanocapsules
05/17/2012US20120121668 Compositions for oral adminstration of active principles requiring masking of taste
05/17/2012US20120121667 Pharmaceutical Composition
05/17/2012US20120121665 Implantable or insertable medical device resistant to microbial growth and biofilm formation
05/17/2012US20120121664 Gastric Acid Secretion Inhibiting Composition
05/17/2012US20120121663 Treatment using dantrolene
05/17/2012US20120121662 Treatment using dantrolene
05/17/2012US20120121656 Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
05/17/2012US20120121654 Nanoparticle isoflavone compositions & methods of making and using the same
05/17/2012US20120121653 Novel mometasone compositions and methods of making and using the same
05/17/2012US20120121651 Pyrazolopyridines and analogs thereof
05/17/2012US20120121650 Chimeric Virus Vaccines
05/17/2012US20120121648 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
05/17/2012US20120121620 Anti-estrogen and immune modulator combinations for treating breast cancer
05/17/2012US20120121618 Predicting And Treating Prostate Cancer
05/17/2012US20120121610 Therapeutic agent and assay
05/17/2012US20120121608 Use of sam68 for modulating signaling through the tnf receptor
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121595 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
05/17/2012US20120121593 Method for determining predisposition to pulmonary infection
05/17/2012US20120121588 Modulation of pilr receptors to treat sepsis
05/17/2012US20120121582 Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related Disease
05/17/2012US20120121579 Treatment of oncostatin m receptor beta mediated heart failure
05/17/2012US20120121575 Prohibitin as target for cancer therapy
05/17/2012US20120121572 New medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity
05/17/2012US20120121567 Ophthalmic solution for protecting internal structures of the eyeball against uv-a rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
05/17/2012US20120121566 Solubilized CoQ-10
05/17/2012US20120121559 Treatment and prevention of pathological conditions using iduna related techniques and compositions
05/17/2012US20120121556 Methods of using regenerative cells to promote wound healing
05/17/2012US20120121554 Hmg-coa secondary metabolites and uses thereof
05/17/2012US20120121551 Compositions and methods for immunostimulatory rna oligonucleotides
05/17/2012US20120121542 Red-shifted opsin molecules and uses thereof
05/17/2012US20120121541 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
05/17/2012US20120121540 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections
05/17/2012US20120121537 Methods and Compositions for Inhibiting Hepatitis C Virus Replication
05/17/2012US20120121536 Compositions and methods for glucose transport inhibition
05/17/2012US20120121533 Nucleic acid ligands to ll37
05/17/2012US20120121532 Process for making dry and stable hemostatic compositions
05/17/2012US20120121531 Biocomposite for artificial tissue design
05/17/2012US20120121530 Vasoprotective and cardioprotective antidiabetic therapy
05/17/2012US20120121527 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPARy TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF
05/17/2012US20120121516 Emulsion Activatable by Ultrasounds and Method for Producing Same
05/17/2012US20120121510 Localized therapy following breast cancer surgery
05/17/2012US20120121503 Inhibition Of CD69 For Treatment Of Inflammatory Conditions
05/17/2012US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
05/17/2012US20120118991 Concentrated mast cell stabilizing pharmaceutical formulations
05/17/2012CA2742532A1 Treatment or prevention of fungal infections with pdk1 inhibitors
05/16/2012EP2453017A1 Oligonucleotides for use in prophylaxis and/or treatment of TGF-beta1 and TGF-beta2, TGF-beta2 and TGF-beta3, TGF-beta1 and TGF-beta3, or TGF-beta1, TGF-beta2, and TGF-beta3 mRNA overexpressing diseases
05/16/2012EP2453009A1 Methods of organ regeneration
05/16/2012EP2452944A1 Diphenyl sulfide derivatives and medicines containing same as active ingredient
05/16/2012EP2452940A1 Azabicyclo compound and salt thereof
05/16/2012EP2452939A2 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist
05/16/2012EP2452937A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
05/16/2012EP2452935A2 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
05/16/2012EP2452934A1 N-phenyl-1-sulfonyl-2-pyrrolidine carboxamides libraries for the identification of biological and pharmacological activity
05/16/2012EP2452891A2 Complementary personal lubricant compositions and delivery system
05/16/2012EP2452685A1 Buffered compositions for dialysis
05/16/2012EP2452684A2 Micelles
1 ... 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 ... 7860